Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Comprehensive Loss

v3.7.0.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenue, net $ 13,085 $ 9,432
Cost of revenue (excluding amortization of $3,770 and $3,812 respectively) 6,641 6,910
Gross profit 6,444 2,522
Operating expenses:    
Sales and marketing 5,462 10,358
Research and development 1,647 2,292
General and administrative 10,504 16,922
Acquisition related amortization expense 3,770 3,812
Asset impairment 3,363 635
Loss on extinguishment of debt 1,873
Goodwill impairment 15,666
Change in fair value of contingent consideration (11,860) (7,993)
Total operating expenses 12,886 42,930
Operating loss (6,442) (40,408)
Interest expense (2,144) (3,705)
Other income (expense), net 14 (93)
Loss from continuing operations before tax (8,572) (44,206)
Benefit from income taxes from continuing operations (162) (13,136)
Loss from continuing operations (8,410) (31,070)
Discontinued Operations    
(Loss) income from discontinued operations (886) 10,341
Gain on sale of assets 1,326 21,634
Income from discontinued operations 440 31,975
Provision for income tax on discontinued operations 362 12,261
Income from discontinued operations, net of tax 78 19,714
Net loss (8,332) (11,356)
Unrealized holding loss on available-for-sale securities, net (3)
Comprehensive loss $ (8,332) $ (11,359)
Basic and diluted (loss) income per share of common stock:    
From continuing operations (in dollars per share) $ (4.63) $ (20.08)
From discontinued operations (in dollars per share) 0.04 12.74
Net loss per basic and diluted share of common stock (in dollars per share) $ (4.59) $ (7.34)
Weighted average number of common shares and common share equivalents outstanding:    
Basic (in shares) 1,816 1,548
Diluted (in shares) 1,816 1,548